Focal Lesious of Thyroid Gland: efficacy of individual Iouide Prophylaxis
https://doi.org/10.14341/ket20073143-49
Abstract
To determine the effectiveness of potassium iodide (200 mkg) to focal changes there was a clinical study taken. Only the patients with focal changes in thyroid were included. The main group was represented with 29 patients with normal thyroid volume and took potassium iodide. 27 patients were included into the group under control and underwent dynamic examination. The third group was consisted of 13 patients with thyroid goiter and getting potassium iodide (200 mkg). The examination of the patient with focal changes of thyroid was suspected to check thyroid status: thyroid ultrasound study, TSH serum level and antibodies to TPO at the beginning, in six months and in 12 months. Follow-up period for each patient was 12 months. Physiological iodide dose recommended with the aim of prophylaxis was apt to prevent the growth of the existent focal changes in thyroid tissue but not led to their full regression; prevent new focal changes in thyroid tissue; normalize thyroid volume in patients with thyroid goiter; do not influence on TSH levels and antybodies to TPO in patients with focal changes in thyroid tissue.
References
1. Браверман Л.И. Болезни щитовидной железы. М.: Медицина, 2000.
2. Герасимов Г.А., Фадеев В.В., Свириденко Н.Ю. и др. Йоддефицитные заболевания в России. М., 2002.
3. Дедов И.И., Свириденко Н.Ю., Герасимов Г.А. и др. Использование таблетированных препаратов йода для профилактики эндемического зоба // Проблемы эндокринологии. 1998. № 1. С. 24-27.
4. Клинические рекомендации Российской ассоциации эндокринологов (РАЭ) по диагностике и лечению узлового зоба // Материалы Третьего Всероссийского тиреоидологического конгресса “Диагностика и лечение узлового зоба”. М., 2004. С. 5-12.
5. Фадеев В.В. Заболевания щитовидной железы в регионе легкого йодного дефицита: эпидемиология, диагностика, лечение. М., 2005.
6. Фадеев В.В. Патогенетическая терапия эутиреоидного зоба // Consilium Medicum. 2002. Т. 4. № 10. С. 516-520.
7. Brander A., Viikinkoski V.P., Nickels J.I., Kivisaari Z.M. Importance of thyroid abnormalities detected at US screening: a 5-year follow-up // Radiology. 2000. V. 215. P. 801-806.
8. Burguera B., Gharib H. Thyroid incidentalomas. Prevaence, diagnosis, significance and management // Endocrin. Metab. Clin. North. Am. 2000. V. 29. P. 187-203.
9. Ezzat S., Sarti D.A., Cain D.R., Braunstein G.D. Thyroid incidentalomas. Prevalence by palpation and ultrasonography // Arch. Intern. Med. 1994. V. 154(16). Р 1838-1840.
10. Hintze G., Emrich D., Koebberling J. Treatment of endemic goitre due to iodine deficiency with iodine, levothyroxine or both: results of a multicentre trial // Eur. J. Clin. Invest. 1989. V. 19. N 6. P. 527-534.
11. Schumm P.M., Usadel K.H., Strohm W.D. et al. Strumalangzeittherapy mit Thyroxin und Iodid // Inn. Med. 1983. V. 10. P. 203.
Review
For citations:
, , Focal Lesious of Thyroid Gland: efficacy of individual Iouide Prophylaxis. Clinical and experimental thyroidology. 2007;3(1):43-49. (In Russ.) https://doi.org/10.14341/ket20073143-49
Views:
20367
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
